INTRODUCTION
The neurotransmitter GABA, by binding to its ionotropic receptor (GABA A R), mediates the flux of Cl À and HCO 3 À in neurons. The opening of these receptors produces an inhibitory or excitatory response depending on the reversal potential for GABA (E GABA ), mediated mainly by the intracellular Cl À concentration ([Cl À ] i ), and its relation to the neuron's resting membrane potential (RMP) . If E GABA is negative to RMP, GABA A R activation will lead to an influx of Cl À and inhibition. However, if E GABA is positive to RMP, GABA A Rs activation will mediate the efflux of Cl ] i so that GABA A R activation leads to hyperpolarization Kahle et al., 2008) . The neuronal [Cl À ] i is set by the balance of Cl À fluxes across the neuronal membrane. These fluxes include Cl À movement through GABA A R channels (Huguenard and Alger, 1986; Staley and Proctor, 1999; Thompson and Gahwiler, 1989) , voltage-gated Cl À channels (Staley, 1994) , the Cl À /HCO 3 À exchanger (Gonzalez-Islas et al., 2009) , and in particular, two cation-chloride cotransporters: NKCC1, an electroneutral importer of Cl À , and KCC2, an electroneutral extruder of Cl À (Payne et al., 2003) . NKCC1 is highly expressed in the hippocampus and neocortex at birth in rodents and humans (Dzhala et al., 2005; Plotkin et al., 1997; Wang et al., 2002) . High levels of NKCC1 expression are correlated with an elevated [Cl À ] i Shimizu-Okabe et al., 2002) . During early postnatal development, as NKCC1 expression decreases, KCC2 expression increases. This change in transporter expression has been demonstrated to underlie the lowering of neuronal [Cl À ] i in the hippocampus (Dzhala et al., 2005; Rivera et al., 1999) . However, the transition from NKCC1 to KCC2 expression does not occur synchronously throughout the whole central nervous system (Stein et al., 2004) .
The ontogeny of KCC2 mRNA expression follows a caudalrostral pattern. Spinal cord and subcortical neurons begin to express KCC2 early during embryogenesis, while KCC2 expression in cortical neurons increases after birth (Stein et al., 2004; Wang et al., 2002) . These expression patterns of NKCC1 and KCC2 suggest that at birth, GABA should have a more inhibitory effect in spinal and subcortical neurons compared to cortical neurons, but there is no direct evidence for a differential effect of GABA on cortical versus subcortical structures.
We considered the possibility that the clinical manifestation of cortical seizure activity is influenced by differences in cortical versus subcortical ontogeny of the Cl À transporters that determine the polarity of GABA A currents. Convulsions are the muscle contractions arising as a consequence of cortical electrographic seizures. However, cortical seizure activity is neither necessary (Kreindler et al., 1958) nor sufficient (Gale, 1992) for convulsive activity. For example, absence seizures involve most of the cortex, but do not cause convulsions (Hughes 2009 ). Convulsions can be blocked by selective inhibition of subcortical structures (Iadarola and Gale, 1982) . 2-deoxyglucose, Fos, and single positron emission computed tomography studies indicate that cortical seizure activity that does not produce convulsive activity activates only the cortex, whereas seizure activity that produces convulsions also activates subcortical structures including the thalamus (White and Price, 1993; Blumenfeld et al., 2009) . These studies support the idea that convulsions arise as a consequence of both cortical and subcortical activity (Gale 1992; Blumenfeld 2002) , so that inhibition of activity in either area could suppress convulsions. Electrographic neonatal seizures frequently have no clinical manifestations, a phenomenon referred to as electroclinical uncoupling (Boylan et al., 2002; Castro Conde et al., 2005; Connell et al., 1989; Painter et al., 1999; Rennie and Boylan, 2003) . Phenobarbital (PB), an allosteric modulator of GABA A R (Twyman et al., 1989) , is the drug of choice for treating neonatal seizures (Carmo and Barr, 2005) . Video-EEG studies have demonstrated that PB inhibits electrographic seizure activity much less effectively than clinically apparent convulsive activity. This differential efficacy exacerbates electroclinical uncoupling (Clancy et al., 1988; Connell et al., 1989; Rennie, 1997; Scher et al., 2003) so that the incidence of electroclinical uncoupling in neonates is 80% after anticonvulsive treatment (Boylan et al., 1999 (Boylan et al., , 2002 Murray et al., 2008; Scher et al., 2003; Weiner et al., 1991) .
To gain insight into mechanisms of electroclinical uncoupling and its exacerbation by PB, we tested the hypothesis that neurons in the neocortex and subcortical structures maintain different [Cl À ] i during postnatal development, using the genetically expressed, Cl-sensitive dual wavelength fluorescent protein Clomeleon (Kuner and Augustine, 2000; Berglund et al., 2006) . We then tested whether these regions have oppositely directed responses to GABA A R agonists and PB, and whether bumetanide, an NKCC1 blocker, preferentially alters the responses to GABA in cortical areas expressing high levels of NKCC1. ] i will also be different in these two structures (Wang et al., 2002; Yamada et al., 2004) . Gramicidin-perforated patch recording is routinely used to measure [Cl À ] i . However, the membrane pores formed by gramicidin, while impermeable to Cl À , allow the flux of Na + , which can alter NKCC1 activity because this transporter relies on the transmembrane Na + gradient for its function . In addition, this technique is time consuming, which limits the number of neurons that can be sampled. To circumvent these problems, we tested whether [Cl À ] i is higher in the neocortex than in the ventroposterior (VP) thalamus during early development by noninvasively measuring neuronal [Cl À ] i in hundreds of cells with single-cell resolution using two-photon imaging of Clomeleon, an optogenetic Cl À indicator. In CML-1 mice, Clomeleon is expressed in both the neocortex and thalamus Kuner and Augustine, 2000) . Clomeleon is a dual wavelength fluorophore, and the fluorescence ratio provides a quantitative readout of ionic concentration that is independent of indicator intensity (Bright et al., 1989 We imaged the neocortical layers IV and V and VP thalamus at P5-6, the earliest age at which there was sufficient expression of Clomeleon. Two main findings were observed: first, [Cl] i was widely distributed in both structures at and P20 (Figures 1A and 1B) . Second, neurons in the VP thalamus always had a significantly lower [Cl À ] i than those in the neocortex ( Figure 1C ; Table 1 (Wang et al., 2002) , and support the idea of a caudal-rostral pattern of maturation of neuronal Cl À transport (Stein et al., 2004) .
RESULTS

Ventroposterior
GABA Effects Are Inhibitory in VP Thalamus but Excitatory in the Neocortex during Early Development
Our results indicate a lower [Cl À ] i in thalamus as compared to that in neocortex, yet GABA actions depend on the relation between RMP and E GABA , which is mainly determined by [Cl
This relationship is surprisingly difficult to measure (Tyzio et al., 2003) due to the aforementioned difficulties with the influence of direct recording techniques on the neurons' internal ionic milieu. To avoid this problem, we used extracellular multiunit activity (MUA) recordings that do not alter the intracellular milieu yet provide a direct measure of the net effect of GABA A R activation on the frequency of network action potentials (Cohen and Miles, 2000; Dzhala and Staley, 2003) . MUA were recorded in rat VP thalamus at early ages (P3-4 and P7-8) in the presence of 2 mM kynurenic acid to block all ionotropic glutamate receptors. Isoguvacine (ISO; 10 mM), a GABA A R agonist, induced a significant initial decrease in MUA frequency at P3-4 in 86% of the slices (6/7 slices; Figure 2 ). This decrease indicates that the net effect of GABA A R activation was inhibitory in the thalamus. The inhibitory effects of ISO persisted in 100% of the slices at P7-8 (n = 5; p = 1, Fisher's exact test between P3-4 and P7-8; Figure 2 ). In contrast, ISO induced an initial increase in MUA in the rat neocortex at P9-10 in 89% of the slices (8/9 slices), an increase that is consistent with an excitatory net effect of GABA A R activation ( Figure 2 ). We were unable to record spontaneous MUA in the rat neocortex at earlier ages, which precluded the determination of GABA A R agonist effects on MUA frequency. However, we were able to measure [Cl À ] i directly in neocortical neurons at these ages.
Figure 2 also demonstrates a late decrease in MUA in some of the neocortical recordings. We have previously demonstrated that ion flux due to persistent GABA A R activation by exogenously applied agonists rapidly overcomes NKCC1 transport capacity , so that E Cl equilibrates near RMP. Under these conditions, GABA A R activation is shunting and inhibitory (Mann and Paulsen, 2007) . For this reason, we only analyzed the initial response to ISO.
In summary, the MUA experiments demonstrate that the actions of GABA during early development are inhibitory in the thalamus while mainly excitatory in the neocortex. These results are consistent with the [Cl À ] i measurement obtained through
Clomeleon. Therefore, if GABA has more inhibitory effects in the thalamus, we hypothesized that PB, a GABA A R-positive modulator (Twyman et al., 1989) , will be more effective in decreasing epileptiform activity in this structure than in the neocortex. We turned to the thalamo-cortical preparation as an ideal preparation to study a synaptically connected subcortical (VP thalamus) and cortical (neocortex layer IV/V) structure. Thalamo-Cortical Epileptiform Activity Induced in Early (P9-10) Development Thalamo-cortical slices have been used to study the effect of anticonvulsive drugs in the adult brain . Because of the observed differences in neuronal [Cl À ] i in the thalamus and neocortex during early development, we took the advantage of thalamo-cortical slices to study the effects of PB, an allosteric GABA A R modulator (Macdonald and Twyman, 1992) and the most commonly used anticonvulsive drug in neonatal seizure treatment (Carmo and Barr, 2005) , in these interconnected brain structures. This preparation allowed us to measure epileptic activity in synaptically linked cortical and subcortical structures as a test of our hypothesis regarding the mechanisms of electroclinical uncoupling. Epileptiform activity was recorded from rat thalamo-cortical slices (P9-10) prepared using a modification of the Agmon and Connors (1991) procedure (see Experimental Procedures, Figure 3A ). Epileptiform activity was not sufficiently stable at earlier postnatal ages, precluding their study. Synchronized epileptiform activity in the neocortex and thalamus was recorded during perfusion of 0 MgCl 2 (low-Mg 2+ )
aCSF ( Figures 3B and 3C ). The broadband (1-500 Hz) power of the extracellular field potential recordings was calculated in a series of 30 s epochs across the entire recording (see Experimental Procedures and Figures S4C and S4D available online, as well as Figure 3D for a shorter time span of signal power calculation). This approach allowed us to measure the power of the epileptiform activity as a function of time (Dzhala et al., 2005) . At P9-10, epileptiform activity simultaneously recorded in thalamus and neocortex was stable for 90 min, and an analysis of variance every 10 min confirmed no change in the signal power over the entire recording ( Figures 3D and 3E ) . Therefore, we used this preparation to study the effects of PB in the synaptically connected thalamus and neocortex as early as P9-10. ( Figure 1 ) and steady-state thalamo-cortical differences in the effects of GABA A R activation (Figure 2 ) support the hypothesis that there are corresponding differences in the effects of positive allosteric modulators of GABA A R such as PB (Twyman et al., 1989) . However, activity-dependent increases in neuronal [Cl
have been observed in a number of preparations (Misgeld et al., 1986; Huguenard and Alger, 1986; Staley and Proctor, 1999) and sustained increases in neuronal [Cl À ] i have been observed in immature hippocampal neurons following trains of action potentials (Fiumelli et al., 2005; Brumback and Staley, 2008) and seizure activity (Khalilov et al., 2003) . To ascertain that the relationship between thalamic and cortical neuronal [Cl À ] i was not changed during seizure activity, we repeated the Clomeleon imaging studies illustrated in Figure 1 during seizure activity induced by low-Mg 2+ aCSF in P9-10 thalamo-cortical slice preparations as illustrated in Figure 3 . Extracellular field potential recordings and two-photon confocal imaging of Clomeleon were performed in the neocortex layer IV/V and VP thalamus either separately (n = 5) or simultaneously (n = 3).
[Cl À ] i was measured every 10 min before and after onset of epileptiform activity. Recurrent interictal and ictal-like epileptiform discharges were detected in all neocortical recordings (n = 5) and in two out of four recordings in the thalamus. In two more recordings from the thalamus, application of low-Mg 
PB Is More Effective in Decreasing Epileptiform Activity in Thalamus than in Neocortex in Early Development
Extracellular MUA recordings were recorded after a period of stable epileptiform activity (low-Mg 2+ ) of at least 30 min duration. Baseline control recordings consisted of stable epileptiform activity for at least 20 min, after which PB (100 mM) was perfused ( Figures 5A-5C ). The efficacy of PB was determined by comparing the mean signal power during the same time windows between thalamus and neocortex and equal-length epochs between control and drug perfusion periods. Consistent with the regional differences in [Cl] i and the effects of GABA A R activation described above, PB significantly decreased epileptiform power in the thalamus (CON: 0.246 ± 0.03 mV Figure S1 ).
Next, we studied the effect of PB on the neocortex and thalamus when the structures were electrically disconnected from each other. We first recorded from coronal brain slices, some of which had their subcortical structures trimmed, in low-Mg 2+ aCSF. Consistent with the ineffectiveness of PB on the neocortex in the thalamo-cortical slices, this drug did not change the epileptiform power in isolated rat neocortical slices at P8 (CON: 1.03 ± 0.33 mV 2 $Hz, PB: 1.21 ± 0.3 mV 2 $Hz; n = 4; p = 0.224, paired t test; PB/CON: 1.25 ± 0.11; Figures 6A-6C ). In addition, PB also failed to decrease epileptiform activity induced by Figures  6D-6F ). We next recorded from the isolated VP thalamus. Epileptiform activity in the disconnected VP thalamus was obtained using horizontal brain slices from P9-10 rat, with an additional cut through the area of thalamo-cortical fibers in the presence of low-Mg 2+ plus 100 mM 4-AP. The electrical activity of the neocortex was simultaneously recorded with the thalamus to verify that there was no synchronous activity between both structures. Using this preparation, the thalamus showed independent epileptiform activity from the neocortex. Consistent with the results in thalamo-cortical slices, the electrically disconnected thalamus showed a significant reduction in epileptiform power in the presence of 100 mM PB (CON: 1.16 ± 0.45 mV 2 $Hz, PB: 0.72 ± 0.27 mV 2 $Hz; n = 6; p = 0.031, Wilcoxon Signed Rank test; PB/CON: 0.65 ± 0.04; Figure 7) . Again, the electrically disconnected neocortex showed no decrease in the presence of PB in these same slices (CON: 0.82 ± 0.32 mV 2 $Hz, PB: 0.75 ± 0.26 mV 2 $Hz; n = 6; p = 0.563, Wilcoxon Signed Rank test; PB/CON: 1.03 ± 0.11).
Therefore, PB failed to reduce epileptiform activity in the neocortex in both connected thalamo-cortical preparations and when disconnected from thalamus, yet this drug reduced thalamic epileptiform activity in the thalamo-cortical slices and in thalami that were disconnected from the neocortex. This suggests that PB is ineffective in the neocortex at this early age of development, whether or not the thalamus is connected. Consequently, in the postnatal period, PB could have regionally specific effects determined by the local neuronal [Cl À ] i.
Bumetanide Plus PB Significantly Decreased Epileptiform Activity in the Neocortex
There is almost a complete lack of KCC2 expression in the neocortex in early development while the expression of NKCC1 persists as late as the second and third postnatal week (Dzhala et al., 2005; Plotkin et al., 1997) . High NKCC1 expression correlates with a higher neuronal [Cl À ] i during early development (Achilles et al., 2007; Brumback and Staley, 2008; Dzhala et al., 2005; Shimizu-Okabe et al., 2002) . Bumetanide is an effective blocker of NKCC1 at low micromolar concentrations (Hannaert et al., 2002; Payne et al., 2003) and has been shown to significantly decrease epileptiform activity in neonatal hippocampus in vitro and in vivo when combined with PB (Dzhala et al., 2005 (Dzhala et al., , 2008 ; but see ). Thus, we tested whether bumetanide would decrease the power of the epileptiform activity in the neocortex without altering thalamic epileptiform activity in the combined thalamo-cortical slice preparation. (2), and 43.4 ± 2.3 mM (3) in the neocortex (C) and 10 ± 0.2 mM (1), 11.1 ± 0.2 mM (2), and 13.2 ± 0.3 mM (3) in the thalamus.
(E) Summary effects of epileptiform activity on intracellular chloride accumulation (mean ± SE; asterisk indicates statistical significance) in the neocortex (268 neurons from n = 3 slices at P9-10) and thalamus (348 neurons from n = 2 slices at P9-10).
After eliciting synchronized epileptiform activity in the thalamocortical preparation with low-Mg 2+ , 100 mM PB plus 10 mM bumetanide (PB+BUM) was perfused. In contrast to PB alone, this drug combination statistically decreased the epileptiform power in the neocortex (CON: 1.3 ± 0.26 mV PB+BUM: 0.46 ± 0.05; Figure S2 ). The effectiveness of PB plus bumetanide in reducing epileptiform activity in the neocortex versus thalamus further supports a difference in GABAergic maturation in cortical versus subcortical structures.
GABAergic Development Is Similar between the Amygdala and Thalamus
To provide additional evidence that PB is effective depending in part on the neuron's [Cl À ] i , we repeated the experiments described for neocortex and thalamus in two different regions, the hippocampus and amygdala. The ontogeny of Cl À transport in the amygdala is similar to the thalamus: they both express KCC2 at very early ages during embryonic development with an almost complete absence of NKCC1. In contrast, the ontogeny of hippocampal Cl À transport closely resembles that of the neocortex (Wang et al., 2002) , and the CA3 hippocampal area is well characterized regarding its GABAergic developmental profile and response to anticonvulsants Dzhala et al., 2008; Dzhala and Staley, 2003; Quilichini et al., 2003; Rivera et al., 1999; Tyzio et al., 2007) . Therefore, we investigated the effects of ISO on MUA frequency recorded in the amygdala (n. medialis) at early postnatal days in the presence of kynurenic acid (2 mM) using the hippocampal CA3 region as an internal control when simultaneous recordings in the amygdala and CA3 region could be performed. Similarly to the thalamus, ISO (10 mM) decreased MUA frequency in the rat amygdala at P3-4 in 9 out of 11 slices recorded (82%; Figure S3 ). In contrast, 10 mM ISO increased the frequency of action potentials recorded in the CA3 region of the hippocampus at the same postnatal age in five out of six slices (83%; Figure S3 ). The inhibitory effect of ISO was similar in the amygdala at P7-8 (100%, n = 7; p = 0.5 Fisher's exact test between P3-4 and P7-8; Figure S3 ) while the excitatory effects of ISO persisted in the CA3 region during this same age in five out of six slices (83%; p = 1 Fisher's exact test between P3-4 and P7-8; Figure S3 ).
PB Is More Effective in Decreasing Epileptiform
Activity in the Amygdala than in the CA3 Region Epileptiform activity was induced in rat P4-6 bran slices by perfusing aCSF with low-Mg
2+
. After a control baseline period, 100 mM PB was perfused. PB had a modest, yet significant, decrease in the signal power of the CA3 region (CON: 0.41 ± 0.09 mV 2 $Hz, PB: 0.31 ± 0.06 mV 2 $Hz; n = 11; p = 0.032, Wilcoxon Signed Rank test; Figure S4 ). In comparison, PB statistically decreased the epileptiform signal power in the amygdala (CON: 0.25 ± 0.04 mV 2 $Hz, PB: 0.14 ± 0.02 mV 2 $Hz; n = 8; p = 0.002, paired t test; Figure S5 ). Moreover, the PB effect in the amygdala was stronger than that in the CA3 region when the PB/CON of the signal power in both structures was compared (Amygdala: 0.60 ± 0.06, n = 8; CA3: 0.84 ± 0.07, n = 11; p = 0.021, unpaired t test), which correlates with the inhibitory effect of ISO in the amygdala, but not the hippocampus. These results support a caudal-rostral development of GABAergic activity as thalamus and amygdala share a similar KCC2-NKCC1 expression pattern and hence a more mature GABAergic signaling than the neocortex and hippocampus, which also share a similar NKCC1-KCC2 pattern and more immature GABA effects.
GABA Effects Are Similar between Regions of the Male and Female Brain
CA1 pyramidal neurons of females rat pups were shown to have a lower [Cl À ] i than those of male pups during early development (Galanopoulou, 2008) . We decided to test if sex differences in GABAergic effects were evident in the CA3 region, thalamus, and amygdala. The effects of ISO recorded in female rats (P4-6) were comparable to the ones recorded in males (female: CA3: 100% of slices increased MUA frequency [n = 6 slices]; Amygdala: 100% of slices decreased frequency [n = 7 slices]; Thalamus: 83% of slices decreased MUA frequency [5/6 slices]; Figure S6 ). Thus, the effects of ISO did not differ between male and female brains in the recorded regions.
DISCUSSION
Our main findings are as follows: (1) 
Measuring Neuronal [Cl
The best methods for measuring neuronal Cl À are still being established. Approaches include gramicidin-perforated patches, which form membrane pores impermeable to anions while allowing the passage of cations (Kyrozis and Reichling, 1995) . A disadvantage of this widely used technique is diffusion of Na + from the intracellular pipette to the neuron, which alters [Na + ] i and the driving force for NKCC1-mediated Cl À transport (Brumback and Shimizu-Okabe et al., 2002) . Cell-attached patches have also been used to estimate E GABA from the reversals of single-channel currents . These methods are less invasive but they have limited time resolution, and may activate stretch-activated potassium channels near the patch (Hammami et al., 2009 ). Both patch techniques are time consuming, so that only limited numbers of neurons can be assayed. Measurement of spontaneous action potential frequency and Clomeleon dye measurements are noninvasive and have the added benefit of recording a significant number of neurons simultaneously (Cohen and Miles, 2000; Dzhala and Staley, 2003) . The large sample sizes reported here provide insight into the heterogeneity of the ontogeny of neuronal Cl À transport not only between but also within regions of the brain. However, action potential measurements do not provide a direct measure of E GABA . Disadvantages of Clomeleon include pH sensitivity, the need for calibration, potential differences in tissue transmission of yellow versus cyan light, and limitation to neurons that express the chromophore. The expression of KCC2 is high in the thalamus during the perinatal period, while NKCC1 expression is low (Li et al., 2002; Stein et al., 2004; Wang et al., 2002) . In the neocortex, NKCC1 expression is high in the perinatal period and decreases progressively the first two postnatal weeks; conversely, embryonic and early perinatal KCC2 expression is low and increases postnatally (Clayton et al., 1998; Plotkin et al., 1997; Yamada et al., 2004 (DeFazio et al., 2000; Hubner et al., 2001; Owens et al., 1996; Rheims et al., 2008a; Sung et al., 2000; Yamada et al., 2004; Zhu et al., 2005) . While NKCC1 and KCC2 appear to be the main transporters setting [Cl À ] i in neurons (Sung et al., 2000; Zhu et al., 2005) , other transmembrane chloride pathways may also be involved including NDCBE (Na + Driven Chloride Bicarbonate Exchanger, also known as SLC4A8; involved in pH regulation) and CLC-2 (conductive Cl À channel) (Chen et al., 2008; Gonzalez-Islas et al., 2009; Romero et al., 2004; Staley, 1994; Staley et al., 1996) . However, the robust effects of NKCC1 inhibition on the efficacy of GABA-mediated inhibition (Figure 8 ; Dzhala et al., 2005; Sipila et al., 2006; Brumback and Staley 2008; Rheims et al., 2008b) indicate that NKCC1 is the primary Cl À accumulator in neocortical and hippocampal neurons. Layer
] i was higher than that in the VP thalamus during early development in agreement with our MUA recordings. The [Cl À ] i developmental profile in neocortex and thalamus is reminiscent of the development of the visual cortex and the dorsal lateral geniculate nucleus (dLGN) (Ikeda et al., 2003) .
] i measurements in vivo are lacking, bumetanide blocked sharp waves recorded in the hippocampus in vivo (Sipila et al., 2006) . Sharp waves are analogous to the giant depolarizing potentials (GDPs) recorded in this area in vitro, and GDPs are also blocked by bumetanide (Dzhala et al., 2005) . This suggests that the higher [Cl À ] i recorded in vitro during early development ; Figure 1 ) is also present in vivo. Neonatal seizures occur most commonly several hours after an acute cerebral injury (Tekgul et al., 2006) . Hypoxia has been shown to cause both a late increase in NKCC1 expression (Yan et al., 2003) and a delayed increase in neuronal [Cl À ] i (Pond et al., 2006 Figure 4) . Thus in the setting of posthypoxic seizures in human neonates that express high levels of NKCC1 in cortical neurons (Dzhala et al., 2005) , the balance of evidence suggests that GABA A R activity is excitatory in the cortex during neonatal seizures.
Our (Owens et al., 1996; Yamada et al., 2004 ), yet we demonstrate a wide intra-area variation that is difficult to observe with direct recording methods because of the number of neurons that must be recorded (Ebihara et al., 1995 ] i variation suggests that some neurons will have E GABA above RMP while in others it will be below RMP. Therefore, the net effect of drugs that modulate GABAergic transmission will depend on the proportion as well as the classes of neurons having excitatory and inhibitory actions of GABA.
The Problem of Electroclinical Uncoupling
The EEG preferentially records neocortical activity (Marks et al., 1992) . As described in the Introduction, convulsions are the motor manifestation of cortical seizure activity; however, this activity, recoded electrographically, is neither necessary nor sufficient to produce convulsive activity in human neonates (Mizrahi and Kellaway, 1987; Connell et al., 1989; Scher et al., 2003; Murray et al., 2008) . Thus many neonates have convulsions with no cortical EEG correlate (Mizrahi and Kellaway, 1987) , and neonates frequently manifest electrographic seizure activity without convulsive activity (electroclinical uncoupling; Scher et al., 2003) . The prominent role of subcortical networks in the production of convulsive activity (Gale, 1992; White and Price, 1993; Blumenfeld et al., 2009 ) frames the hypothesis that selective inhibition of subcortical structures could suppress convulsive activity, but not electrographic cortical seizure activity, in neonates, and this selective inhibition could arise from the differential neuronal Cl À transport (Stein et al., 2004) (Figure 1) , and consequent effects of GABA A R activation (Figure 2 ) in these structures.
The Modulatory Effects of Anticonvulsant Drugs
The low efficacy of PB in suppressing cortical versus thalamic epileptiform activity in our experiments comprises a candidate mechanism for the exacerbation of electroclinical uncoupling by PB. PB exhibited the same efficacy in the perinatal thalamus as in adult in vitro thalamo-cortical preparations as well as in vivo (Hosford et al., 1997) , and this efficacy was not improved by bumetanide, supporting the idea that in the perinatal period, thalamic neurons have developed mature patterns of neuronal Cl À transport (Stein et al., 2004) , GABA A signaling (Figure 2) , and anticonvulsant responses to PB ( Figure 5 ). We used the thalamus as a model subcortical structure because of the high correlation between thalamic activation and convulsive activity (White and Price 1993; Blumenfeld et al., 2009 ) as well as the high expression of Clomeleon in the perinatal CML-1 mouse (Berglund et al., 2008) . However, electroclinical uncoupling could also arise as a consequence of a higher efficacy of PB in any subcortical network involved in transmission of convulsive activity, including the spinal cord, a region with the earliest KCC2 expression (Stein et al., 2004) . Although the anticonvulsant effects of PB in human neonates are poor when measured electrographically, they are not absent (Painter et al., 1999) . Similarly, we observed modest but significant anticonvulsant effects in our experiments in area CA3, even though GABA appeared excitatory in this region based on the net increase in action potential frequency in response to perfusion of a GABA A R agonist. There are several reasons why PB could exhibit anticonvulsant activity in structures with excitatory responses to GABA A R activation. During seizure activity, paroxysmal depolarizing shifts (PDSs) in the membrane potential result in membrane potentials that are very positive to the GABA reversal potential, even in immature neurons. Thus, GABA A R activation can repolarize the membrane potential relative to the PDS even though E GABA is more positive than RMP. Additionally, high concentrations of GABA agonists or allosteric modulators may result in Cl À fluxes through the GABA A R that are sufficiently large and prolonged to change [Cl À ] i and so shift E GABA toward RMP Staley and Proctor, 1999) , in which case GABA A R activation would provide effective shunting inhibition. Further, in a network of neurons, a variety of E GABAs are apparent (Figure 1) . Thus, the effect of PB on the network is even less predictable than in an individual neuron. Finally, PB may have other anticonvulsant actions besides allosteric modulation of GABA A R (Kitayama et al., 2002) . These issues may underlie the sometimes conflicting results of different investigators regarding the anticonvulsant efficacy of allosteric modulators of GABA A R (Dzhala et al., 2005 (Dzhala et al., , 2008 Kilb et al., 2007; Wells et al., 2000) . Our results provide evidence that PB's anticonvulsant efficacy parallels the efficacy of GABA A R-mediated inhibition (Dzhala et al., 2005; Quilichini et al., 2003) .
The thalamocortical recordings demonstrate differential PB effects in two synaptically coupled networks of neurons that maintain distinct [Cl] i . The different effects of PB in these structures correspond to the opposite effects of ISO on MUA frequency, the differences in neuronal [Cl À ] i , and the previously reported differences in KCC2 versus NKCC1 expression in these two areas. This combined preparation provides experimental support for the hypothesis that exacerbation of electroclinical uncoupling arises from the selective anticonvulsant efficacy of PB in subcortical versus cortical regions.
Bumetanide and Its Potential Role in Electroclinical Uncoupling
Drugs that reduce the [Cl À ] i by blocking NKCC1 activity, e.g., bumetanide, improve the electroencephalographic anticonvulsive effects of PB in vitro and in vivo (Dzhala et al., 2005 (Dzhala et al., , 2008 . In Swiss mice, bumetanide alone decreased seizure activity in the neocortex during early development (Rheims et al., 2008b) and the effect of bumetanide is synergistic with PB (Dzhala et al., 2008) . This drug combination could be of significant impact in the human neonate, and therefore we studied these two drugs in conjunction. This synergistic effect statistically decreased the epileptiform activity in the neocortex, whereas PB alone did not. The anticonvulsant effects of PB were not enhanced by bumetanide in the thalamus. Thus the anticonvulsant effect of bumetanide would be more evident electrographically rather than clinically: neonates whose convulsions were already suppressed by selective effects of PB on subcortical networks could not manifest additional reductions in convulsions, but electrographic seizure activity could be reduced.
Neuronal NKCC1 is upregulated in adult patients suffering from chronic temporal lobe epilepsy, so bumetanide might be helpful in this population (Huberfeld et al., 2007; Palma et al., 2006) . Posthypoxic increases in NKCC1 expression (Yan et al., 2003) and neuronal chloride are seen in adult neurons experimentally (Pond et al., 2006) , and electroclinical uncoupling has recently been observed in critically ill adult patients (Oddo et al., 2009 ), but it is not known whether pharmacological inhibition of NKCC1 is useful in this setting.
KCC2 and NKCC1 expression patterns in the developing human parietal cortex are similar to the levels found in rat neocortex (Dzhala et al., 2005) , although the pattern of expression of these transporters in subcortical structures has not been studied in humans. Bumetanide has been extensively studied as a diuretic in human neonates (Lopez-Samblas et al., 1997; Sullivan et al., 1996) . More recent experiments indicate that long-term suppression of NKCC1 activity and chronic KCC2 overexpression produce alterations in migration patterns of neocortical principal neurons and their dendritic length (Ge et al., 2006; Cancedda et al., 2007; Wang and Kriegstein, 2008) . However, long-term changes in brain activity due to NKCC1 block during seizures have not been studied. Most human neonates would not require long-term treatment with bumetanide; the majority of neonatal seizures are an acute reaction to brain injury (Tekgul et al., 2006) , and under these circumstances anticonvulsant treatment can usually be discontinued after the first week of life (Carmo and Barr, 2005) . Recently, bumetanide treatment was reported to decrease seizure duration and frequency in a 6-week-old baby girl with anticonvulsant-resistant status epilepticus secondary to meningitis (Kahle et al., 2009) . A pilot trial of bumetanide for neonatal seizure treatment is currently under way (http://clinicaltrials.gov/ number NCT00830531).
In conclusion, our results support the hypothesis of a caudalrostral functional maturation of GABA actions and provide a candidate pathophysiological mechanism of neonatal electroclinical uncoupling as well as a pharmacotherapy that could be beneficial in this condition.
EXPERIMENTAL PROCEDURES Slice Preparation
Postnatal (ages: P3-10) male (female where indicated) Sprague-Dawley rats and CLM-1 Clomeleon mice (P5-P20; C57bl/6 background) were anaesthetized and decapitated according to a protocol approved by the Massachusetts General Hospital Center for Comparative Medicine. The brain was removed and placed in ice-cold aCSF containing (in mM) NaCl (120), KCl (3.3), CaCl 2 (1.3), MgCl 2 (2), NaH 2 PO 4 (1.25), NaHCO 3 (25), and D-glucose (10) with pH 7.3-7.4 when bubbled with 95% O 2 and 5% CO 2. Coronal and horizontal brain slices, 450-500 mm thick, were cut with a Leica VT1000S Vibratome (Leica Microsystems, Wetzlar, Germany) in aCSF containing 2 mM kynurenic acid (Sigma; St. Louis, MO). In a subset of coronal slices, subcortical structures were trimmed. Thalamo-cortical brain slices were obtained by modifying the procedure of Agmon and Connors (1991) as follows: after exposing the brain by removing the parietal, temporal, and occipital bones, a 45 angle coronal cut was performed before removing the brain from the base of the cranium, and its rostral end was glued to the vibratome dish. Slices were placed into an interface holding chamber kept at room temperature and stored for at least 1 hr before being transferred to the recording chamber.
Electrophysiology
Brain slices were placed in an upright microscope (Zeiss, Axioskop; Thornwood, NY) perfused with aCSF (0.5 mM MgCl 2 to increase spontaneous activity when recording MUA) held at 32 C-34 C and aerated with 95% O 2 -5% CO 2 (flow rate of 5-8 ml/min). Tungsten-coated electrodes were placed in neocortex layer IV/V, CA3 region of the hippocampus, amygdala (n. medialis), and thalamus (VP nucleus). Recordings were obtained through a CyberAmp 320 amplifier (Molecular Devices, Sunnyvale, CA) with a x10,000 gain, digitized at 10 KHz with a DigiData 1321A (Molecular Devices), and recorded with pClamp (Molecular Devices). Epileptiform activity was induced by perfusing the brain slices with aCSF containing 0 MgCl 2 (lowMgCl 2 ) or 4-AP and recordings were started after 30 min of consistent epileptiform activity. Drugs were perfused as indicated.
Imaging Two-photon imaging was performed using a Fluoview 1000MPE with prechirp optics and a fast acousto-optical modulator (AOM) mounted on a Olympus BX61WI upright microscope (Olympus Optical) using a 20x water immersion objective (NA 0.95; Figure S7A ). A mode-locked Ti:Sapphire laser (MaiTai, Spectra-Physics, Fremont, CA) generated two-photon fluorescence with 860 nm excitation. CFP and YFP filters (340-480 and 500-540 nm, respectively) and two photomultiplier tubes (Hamamatsu Photonics) were used to simultaneously acquire CFP and YFP signals. 3D stacks were imaged. Slices were perfused with aCSF held at 32 C-34 C and aerated with 95% O 2 -5% CO 2 .
Analysis
Multiunit Activity Detection and Analysis
Recordings were high-pass filtered at 10 Hz. Events were detected by Minianalysis (Synaptosoft, Inc., Fort Lee, NJ). ISO effect was determined by using a peak function running under Origin (OriginLab Corporation, Northampton, MA) based on the following equation: (1)
where y0 is the offset, A is amplitude, xc is the center, and w is the width. The first peak (either negative or positive) after perfusion of ISO was taken as the effect of this drug. Epileptiform Activity Analysis A custom-written macro running under IGOR Pro v6 (Lake Oswego, OR) was used. Briefly, the complete trace was loaded and down sampled to 2 kHz. For each epoch of 30 s, its mean value was subtracted and Fast Fourrier Transformed using Hann window apodization. Next, the Fast Fourier Transform (FFT) was smoothed with a median window of 7 points and divided by the total number of points, and the signal power area (1-500 Hz) was calculated ( Figures S4B and S4C ). The wide-band power is mathematically identical to the square of the field potential, and thus represents an unbiased measure to quantify seizure activity (e.g., Figure S2 ; Dzhala et al., 2005 Dzhala et al., , 2008 . The wide-band power is proportionately affected by the frequency of discharge and the fraction of the population participating in the discharge. Finally, the mean signal power during equal control and drug condition epochs was calculated. This method allowed us to address the combined effect of drugs on the frequency and power of the epileptiform activities. Graphs display the signal power in the EEG band (1-160 Hz) (Bragin et al., 1999 (Bragin et al., , 2004 Khosravani et al., 2005) .
[Cl À ] i Determination Quantitative measurements on 3D stacks were performed using Image J (National Institutes of Health, freeware) offline. The CFP and YFP images were loaded and their respective background value was subtracted for the 3D volume. Next, a median filter was applied to all of the 3D planes. Cells were visually identified, a region of interest (ROI) was drawn around the cell bodies, and the ratio of the YFP/CFP fluorescence intensity was measured. Each cell's YFP/CFP ratio was converted into 
Rmax and K 0 D were free parameters, while Rmin was determined by quenching Clomeleon with 123 mM F À (Duebel et al., 2006; Kuner and Augustine, 2000) .
With single-cell resolution, we calculated Rmax and K 0 D for 47 individual neurons that we were able to follow across all calibration conditions. The K 0 D was 91 ± 5.43 mM, Rmax was 1.026, and Rmin was 0.268 ( Figure S7B ] smaller than 50 mM and produce large deviations at 150 mM (Kuner and Augustine, 2000) . However, this sensitivity of Clomeleon to pH should not affect our [Cl À ] i determination as pH is tightly regulated in neurons (Bonnet et al., 1998) and we performed all of our experiments in resting neurons bathed in CO 2 /HCO 3 À buffered solution which prevents pH i changes. The pH i could be of concern in in vivo preparations, where the pH is not directly controlled; or in experiments known to change pH i . Moreover, there were no exchanges of extracellular solutions or drug perfusion that could alter pH i . Even though we were careful in the calibration of Clomeleon, we also included the statistics on the actual YFP/CFP ratios, which are independent of Cl À calibration.
Statistics
The Shapiro-Wilk test was use to determine if the data followed a Gaussian distribution. The parametric Student t test (paired and unpaired, two-tail) was used if the data were normally distributed while the Wilcoxon-Mann-Whitney test (unpaired data, two-tail) and Wilcoxon Signed Rank test (paired data, two-tail) were used for non-Gaussian distributions. Analysis of variance (oneway ANOVA) was performed when measuring multiple conditions. Statistical analysis of the linear regression slopes was done using a Student t test (Zar, 1999 ). Fisher's exact test (two-tail) was used when comparing proportions. Statistical significance was set to p < 0.05. Values are expressed as mean ± standard error of the mean (SEM).
Drugs ISO was obtained from Tocris (Ellisville, MO). Kynurenic acid, PB, nigericin, tributyltin chloride, 4-AP, and bumetanide were obtained from Sigma (St. Louis, MO). Bumetanide was dissolved in 100% ethanol and made fresh every day.
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